Erschienen in:
08.05.2019 | Original Contribution
Fatty acid intake and breast cancer in the Spanish multicase–control study on cancer (MCC-Spain)
verfasst von:
Trinidad Dierssen-Sotos, Inés Gómez-Acebo, Camilo Palazuelos, Esther Gracia-Lavedan, Beatriz Pérez-Gómez, Madalen Oribe, Vicente Martín, Marcela Guevara, Paz Rodríguez-Cundín, Guillermo Fernández-Tardón, Rafael Marcos-Gragera, Ana Molina-Barceló, Marian Díaz-Santos, Gemma Castaño-Vinyals, Nuria Aragonés, Ana López-Gonzalez, Pilar Amiano, Jesús Castilla, Jessica Alonso-Molero, Manolis Kogevinas, Marina Pollán, Javier Llorca
Erschienen in:
European Journal of Nutrition
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To evaluate the association between dietary fat and fat subtype and breast cancer development.
Methods
We conducted a case–control study with 1181 cases of incident breast cancer, diagnosed between 2007 and 2012, and 1682 population controls frequency matched (by age, sex, and region) from the Spanish multicenter case–control study MCC-Spain.
Results
We found a significant protective effect in premenopausal women of total fat intake [OR 0.51 95% CI (0.31–0.86) highest versus lowest tertile], but no effect was observed in menopausal women [OR 1.15 95% CI (0.83–1.60)]. Analyzing by type of fat, this protective effect persisted only for the monounsaturated fatty acids [OR 0.51 95% CI (0.32–0.82)]. In contrast, other fatty acids did not have a significant effect. In addition, a protection against risk of breast cancer was found when polyunsaturated fats were “substituted” by monounsaturated, maintaining the same total fat intake [OR 0.68 95% CI (0.47–0.99)]. Finally, analyzing by breast cancer subtype, we found no effect, except in premenopausal women where intake of moderate [OR 0.52 95% CI (0.33–0.82)] and high monounsaturated fatty acids [OR 0.47 95% CI (0.27–0.82)] maintains a protective effect against ER/PR + tumors. In contrast, in menopausal women, a high intake of monounsaturated fatty acids was associated with higher risk of HER2 + tumors [OR 2.00 95% CI (0.97–4.13)].
Conclusion
Our study shows a differential effect of monounsaturated fatty acids according to menopausal status and breast cancer subtype.